Catálogo de publicaciones - libros
Título de Acceso Abierto
Paediatric Formulation: Paediatric Formulation
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
dasatinib; Duchenne muscular dystrophy; cyclodextrin inclusion complex; phase solubility studies; paediatric age; liquid formulation; tumorspheres; retinoblastoma; topotecan; penetration; confocal microscopy; poorly water soluble drug; solubility enhancement; grinding; spray congealing; neglected tropical diseases; polymorph; Norvir®; ritonavir; poorly soluble compound; pediatric; palatability assessment; bioavailability; flavor profile; Interleukin-1; anakinra; canakinumab; innovative biotechnologies; autoinflammatory disease; Kawasaki disease; systemic juvenile idiopathic arthritis; personalized medicine; child; pediatrics; neonates; formulation; product development; formulation development; oral; parenteral; topical; inhaled; intra nasal; biopharmaceutics; administration; excipient; NICU; device; medication error; dosage form; modified release; drug delivery; paediatric formulation development; paediatric dosage forms; chronic myeloid leukemia; tyrosine kinase inhibitors; pediatric age; imatinib; nilotinb; ponatinib; Orodispersible formulation; pyrazinamide; pediatric drug delivery; tuberculosis; design of experiments; children; edible films; development; design; paediatric; age-related; palatable; taste-masking; acceptable
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-0365-0741-5
País de edición
Suiza